11.9.2019
News

KŠB Supports Business Law Summer School

The Business Law Summer School organized annually by Masaryk University Law School in Brno, in cooperation with Palacký University Law School, was held this year on 15 - 19 July 2019 once again in Velké Bílovice.

The Summer School’s goal is to provide talented students with deeper insight into business law with an emphasis on the "interweaving of worlds", i.e. the worlds of academia, the judiciary, and legal practice.

Under the leadership of many experienced lecturers (including Vlastimil Pihera, Jan Lasák and Simona Hornochová from KŠB), the students focused on various issues, including family asset management structures and related tax implications, and the liability of company board members.

Other articles

8.7.2025
News

Advising J&T on the preparation of another bond programme – the Europacity Berlin project.

KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
News

A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein

Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
News

KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.